Cel Sci Corporation (CVM)

[GD]

For any longs thinking Geert need more than two month for
full data analysis, CVM need some professional stock pumpers
like NWBO is having and talk to CVM IR and get some leaks about
no data before medical journal publishing, 2 month later
still no data PR, the story change to secret BLA filing and
waiting FDA's approval, what kind of bullsh*t that is going on
at NWBO board, the very simple reason of no TLD PR after 4 month
data lock may be NWBO trial hit the new primary endpoint with
a weak P value 0.04-0.05, but the important secondary endpoints
which include the original OS and PFS endpoints are not SS,
this means NWBO is trying to find support to explain why the
new weak primary endpoint P value is meaningful for approval,
I think FDA and street are going to ask how can NWBO justify
approval with weak efficacy even compare to the historical
control.